Luliconazole Price Trend and Forecast 2026-2027

The US paid the most for luliconazole in Q2 2026: USD 663/KG, up 1.7% from USD 652 in Q1. The steady dermatology-formulation demand kept things firm there. Worldwide, the average moved up 1.7%, to USD 546/KG from USD 537, largely because the imidazole intermediate feedstock costs kept climbing across every region we track. What about H2 2026? We'd expect a global average somewhere in the USD 540-585/KG range, with the steady antifungal-formulation demand doing most of the work overall.

Luliconazole is synthesized from an imidazole intermediate combined with a dichlorophenyl-based building block, producing a topical antifungal active pharmaceutical ingredient developed and first commercialized in Japan before expanding into other major pharmaceutical markets. It feeds cream and solution formulations used to treat fungal skin infections, valued clinically for its potency and relatively short treatment courses compared to some older antifungal agents. Three things move the price more than anything else: the imidazole intermediate feedstock costs, the dermatology-formulation demand tied to prescribing volumes, and how much specialized API production capacity the producers are running.

Japan's originating role in this molecule's development deserves some explanation, since it's shaped where specialized production expertise has concentrated. Because luliconazole was first developed and commercialized by Japanese pharmaceutical companies, the country retains some of the most established manufacturing know-how for this particular chemistry, which is part of why Japanese pricing tends to run at a premium reflecting that specialized production heritage even as generic manufacturing has since expanded to other markets. Buyers new to this market sometimes underestimate how much that structural detail matters until they see it play out in the pricing data over a full cycle, which is exactly why we've made a point of covering it here in detail.

The topical-antifungal demand segment deserves a mention too, since it ties this market's overall consumption to dermatology prescribing patterns specifically, a somewhat different demand driver than the oral antifungal and systemic antibiotic markets that dominate several other pharmaceutical intermediates in this pipeline. That dermatology-specific focus has kept demand fairly steady, tracking routine skin-infection treatment rates rather than the more acute, hospital-driven demand that shapes some other API markets. That distinction is worth keeping in mind for anyone comparing this market to more conventional pharmaceutical intermediates.

Luliconazole Price Forecast for 2026

Supply and demand should stay moderately tight through H2 2026, with the imidazole intermediate feedstock costs doing most of the work on pricing. Japan and the US both kept the dermatology-formulation demand steady through H1, and that's likely to continue. India's formulation sector kept the demand building, while China's large API base kept it the most affordable of the four. None of the four markets we track is showing signs of genuine disruption heading into the back half of the year. None of the four markets we track is showing signs of genuine disruption heading into the back half of the year.

Buyers should keep an eye on the specialized imidazole-intermediate supply chain specifically, since this chemistry requires more processing steps than a simpler generic API, which has kept production concentrated among a relatively small number of experienced manufacturers. That's worth building into any longer-range planning rather than assuming current conditions will simply persist unchanged.

The dermatology-prescribing demand cycle bears watching too, since it tracks routine skin-infection treatment volumes rather than the more acute demand patterns that shape hospital-focused antimicrobial markets.

What could push prices higher? An imidazole intermediate feedstock spike, or a stronger-than-expected dermatology-formulation demand surge across the major markets. What could pull them lower? Expanded low-cost Chinese or Indian API capacity outpacing the demand.

For the Quarter Ending June 2026

Luliconazole Prices Q2 2026:

• China: USD 451/KG
• India: USD 491/KG
• Japan: USD 618/KG
• United States: USD 663/KG

Luliconazole Prices in China

China's luliconazole producers passed through the firmer feedstock costs this quarter, and the domestic formulation demand held steady. The gain came to 1.8%, USD 443/KG to USD 451. That kept China comfortably the most affordable of the four markets.

Why did the price of Luliconazole change in Q2 2026 in China?

The imidazole intermediate feedstock costs firmed through the quarter, and the domestic formulation demand held its ground right alongside that.

Luliconazole Prices in India

India climbed 1.7% to USD 491/KG, the formulation demand continuing to build through the period.

Why did the price of Luliconazole change in Q2 2026 in India?

The formulation demand kept building, and that alone explains most of the move here.

Luliconazole Prices in Japan

Japan gained 1.6% to USD 618/KG, the established origination expertise keeping the demand firm through the period.

Why did the price of Luliconazole change in Q2 2026 in Japan?

Japan's premium held for the usual reason: established production expertise backed by firming feedstock costs.

Luliconazole Prices in United States

USD 663/KG. That's where the US landed in Q2, up 1.7% from USD 652 in Q1. The dermatology demand stayed steady, and the feedstock costs climbed just enough to push things higher.

Why did the price of Luliconazole change in Q2 2026 in United States?

The dermatology demand didn't move much, honestly. It was the imidazole intermediate feedstock costs doing most of the work this quarter.

For the Quarter Ending March 2026

Luliconazole Prices Q1 2026:

• China: USD 443/KG
• India: USD 483/KG
• Japan: USD 608/KG
• United States: USD 652/KG

Luliconazole Prices in China

China gained 1.8% to USD 443/KG, the demand firming as the year opened.

Why did the price of Luliconazole change in Q1 2026 in China?

The domestic formulation demand firmed as the year opened, and the imidazole intermediate feedstock costs edged higher right alongside it.

Luliconazole Prices in India

Indian luliconazole rose 1.7% to USD 483/KG, the formulation demand firming with the new year.

Why did the price of Luliconazole change in Q1 2026 in India?

The formulation demand firmed with the new year, and the feedstock costs kept climbing steadily too.

Luliconazole Prices in Japan

Japanese luliconazole climbed 1.7% to USD 608/KG, the dermatology demand staying firm through the quarter.

Why did the price of Luliconazole change in Q1 2026 in Japan?

The dermatology demand stayed firm, and the feedstock costs firmed alongside it.

Luliconazole Prices in United States

US luliconazole rose 1.7% to USD 652/KG, the dermatology-formulation demand building through the quarter.

Why did the price of Luliconazole change in Q1 2026 in United States?

The dermatology-formulation demand built through the quarter, tracking the prescribing activity closely.

Quarterly Luliconazole Price Trends

The global average climbed steadily across the window, from USD 510/KG in Q1 2025 to USD 546 by Q2 2026, a net gain of about 7.1%. Every quarter posted a gain here, reflecting the firming imidazole intermediate feedstock costs and the steady dermatology-formulation demand across every market we track, with the pace of the gains staying fairly consistent across the entire window. That kind of steady, uninterrupted climb is worth noting, since it stands in contrast to how choppy some other commodities in this space have looked over the same period.

What was Luliconazole Price in 2025?

2025 was a steady year for luliconazole. Starting near USD 510/KG in Q1, the global average finished 2025 at USD 528, a gain of about 3.5%. The dermatology-formulation demand held consistent all year across every market we track, before the pace of gains stayed just as strong once 2026 got underway. The consistency of that pattern across all four regions makes this one of the more predictable specialty-dermatology pharmaceutical markets we track. Buyers who track this market closely tend to view that steady annual pattern as the baseline against which any future quarter's move should be judged.

Luliconazole Prices in China in 2025

Chinese prices moved from about USD 420/KG in Q1 2025 to USD 435 by Q4, up roughly 3.6%. The domestic demand held steady all year, and China stayed the most affordable of the four markets throughout.

Luliconazole Prices in India in 2025

Indian prices climbed from USD 460/KG in Q1 to USD 475 by Q4, a 3.3% gain, tracking the steady formulation demand.

Luliconazole Prices in Japan in 2025

Japanese prices rose from USD 580/KG in Q1 to USD 598 by Q4, up 3.1%, as the established origination expertise kept demand firm through the year.

Luliconazole Prices in United States in 2025

US prices moved from USD 620/KG in Q1 to USD 641 by Q4, a 3.4% gain, the highest absolute price throughout the four markets on the steady dermatology demand.

How We Can Help

Expert Market Research: Your Source for Real-Time Luliconazole Price Intelligence

We keep a continuous eye on the luliconazole prices wherever it's produced or consumed at scale, tracing causation through the imidazole intermediate feedstock economics, the dermatology-formulation demand, and the specialized production capacity utilization. Our analysts track the concentrated pool of experienced manufacturers closely, given how much specialized chemistry knowledge this particular API requires. We also flag any material shift in the underlying feedstock or trade-logistics conditions as soon as it becomes apparent. Need pricing data, bespoke market analysis, or procurement advisory? Reach out to our team.